Mammography benefit in the Canadian National Breast Screening Study-2: A model evaluation

International Journal of Cancer

Volumn 110, Issue 5, 2004, Pages 756-762

  Rijnsburger, Adriana J ^a   Van Oortmarssen, Gerrit J ^a   Boer, Rob ^a,b   Draisma, Gerrit ^a   To, Teresa ^c,d   Miller, Anthony B ^c   De Koning, Harry J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RAND CORPORATION   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Breast cancer; Canadian National Breast Screening Study 2; Clinical breast examination; Mammography; Mortality; Screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST EXAMINATION; CANADA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; CANADA; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 2942607392     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20143     Document Type: Article

References (23)

1. Nyström L, Andersson I, Bjurstam N, Frisell J, Nordenskjöld B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet 2002;359:909-19.
2. Olsen O, Gøtzsche PC. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2001:CD001877.
3. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992;147:1477-88.
4. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000;92:1490-9.
5. Forrest AP, Alexander FE. A question that will not go away: at what age should mammographic screening begin? J Natl Cancer Inst 1995;87:1195-9.
6. van Oortmarssen GJ, Habbema JDF, van der Maas PJ, de Koning HJ, Collette HJA, Verbeek ALM, Geerts AT, Lubbe JThN. A model for breast cancer screening. Cancer 1990;66:1601-12.
7. de Koning HJ, Boer R, Warmerdam PG, Beemsterboer PMM, van der Maas PJ. Quantitative interpretation of age-specific mortality reductions from the Swedish Breast Cancer-Screening Trials. J Natl Cancer Inst 1995;87:1217-23.
8. Miller AB, Howe GR, Wall C. The National Study of Breast Cancer Screening. Protocol for a Canadian randomized controlled trial of screening for breast cancer in women. Clin Invest Med 1981;4:229-58.
9. Muir C, Waterhouse J, Mack T, Powell J, Whelan S, eds. Cancer incidence in five continents. vol. V. Lyon: IARC, 1987.
10. Gaudette LA. Should population-based screening for breast cancer be extended to Canadian women aged 70-79? A model-based approach. Ottawa: School of Graduate Studies and Research, University of Ottawa, 2001. Dissertation.
11. WHO. World health statistics annual. Geneva: WHO, 1984.
12. de Koning HJ, Fracheboud J, Boer R, Verbeek ALM, Collette HJA, Hendriks JHCL, van Ineveld BM, de Bruyn AE, van der Maas PJ. Nation-wide breast cancer screening in the Netherlands: support for breast-cancer mortality reduction. National Evaluation Team for Breast Cancer Screening (NETB). Int J Cancer 1995;60:777-80.
13. Press WH, Flannery BP, Teukolsky SA, Vetterling WT. Numerical recipes. The art of scientific computing (Fortran version). Cambridge: Cambridge University Press, 1989.
14. Miller AB, Baines CJ, Turnbull C. The role of the nurse-examiner in the National Breast Screening Study. Can J Public Health 1991;82:162-7.
15. Baines CJ, Miller AB, Bassett AA. Physical examination - its role as a single screening modality in the Canadian National Breast Screening Study. Cancer 1989;63:1816-22.
16. Bobo JK, Lee NC, Thames SF. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst 2000;92:971-6.
17. Oestreicher N, White E, Lehman CD, Mandelson MT, Porter PL, Taplin SH. Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res Treat 2002;76:73-81.
18. Kopans DB, Feig SA. The Canadian National Breast Screening Study: a critical review. Am J Roentgenol 1993;161:755-60.
19. Gøtzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.
20. Vainio H, Bianchini F, eds. IARC handbooks of cancer prevention. vol. 7. Breast cancer screening. Lyon: IARC, 2002.
21. Nyström L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Rydén S, Andersson I, Bjurstam N, Fagerberg G, Frisell J, Tabár L, Larsson LG. Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet 1993;341:973-8.
22. Holmberg LH, Adami HO, Tabár L, Bergstrom R. Survival in breast cancer diagnosed between mammographic screening examinations. Lancet 1986;2:27-30.
23. Tabár L, Chen HH, Duffy SW, Krusemo UB. Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. Jpn J Clin Oncol 1999;29:608-16.